Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
News and Views
Nature Medicine  2, 1074 - 1075 (1996)
doi:10.1038/nm1096-1074

Immunotherapy for multiple sclerosis: From theory to practice

Jack P. Antel, Burkhard Becher & Trevor Owens

Department of Neurology and Neurosurgery, Neuroimmunology Unit, McGill University Montreal, Quebec H3A 2B4, Canada

T-cell receptor peptide vaccines may hold promise as future therapy for multiple sclerosis (pages 1109−1115).

REFERENCES
  1. Katz, D. et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann. Neurol. 34, 661−669 (1993). | PubMed  | ISI | ChemPort |
  2. Talbot, P.J., Paquette, J.S., Ciurli, C., Antel, J.P. & Ouellet, F. Myelin basic protein and human coronavirus 229E cross-reactive T cells in MS. Ann. Neurol. 39, 233−240 (1996). | PubMed  | ISI | ChemPort |
  3. Lehman, P.V., Forsthuber, T., Miller, A. & Sercarz, E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358, 155−157 (1992). | Article | PubMed  | ISI | ChemPort |
  4. Vandenbark, A.A. Treatment of multiple sclerosis with T-cell receptor peptides: Results of a double-blind pilot trial. Nature Med. 2, 1109−1115 (1996). | Article | PubMed  | ISI | ChemPort |
  5. Ben-Nun, A., Wekerle, H. & Cohen, I.R. Vaccination against autoimmune encephalomyelitis with T-lymphocyte cell lines reactive against myelin basic protein. Nature 292, 60−61 (1981). | PubMed  | ChemPort |
  6. Jerne, N.K. Idiotypic networks and other preconceived ideas. Immunol. Rev. 79, 5−24 (1984). | PubMed  | ISI | ChemPort |
  7. Bell, J.I. & Lathrop, G.M. Multiple loci for multiple sclerosis. Nature Genet. 13, 377−378 (1996). | Article | PubMed  | ISI | ChemPort |
  8. Rudick, R. et al. Clinical outcomes assessment in multiple sclerosis. Ann. Neurol. (in the press).
  9. Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A. & Weiner, H.L. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265, 1237−1240 (1994). | PubMed  | ISI | ChemPort |
  10. Windhagen, A., Anderson, D.A., Carrizosa, A., Williams, R.E. & Hafler, D.A. IL-12 induces human T cells secreting IL-10 with IFN-gamma. J Immunol. 157, 1127−1131 (1996). | PubMed  | ISI | ChemPort |
  11. Brocke, S. et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379, 343−346 (1996). | Article | PubMed  | ISI | ChemPort |
 Top
 Top
References
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1996 Nature Publishing Group | Privacy policy